Literature DB >> 9892950

The natural history of childhood eczema: observations from the British 1958 birth cohort study.

H C Williams1, D P Strachan.   

Abstract

The National Child Development Study (NCDS) is a birth cohort study whose longitudinal design makes it suitable for examining the natural history of common diseases in childhood such as atopic eczema. We have analysed the age of onset and clearance rates for examined and/or reported eczema in 6877 children born during the period 3-9 March 1958 for whom linked data were available at birth and at the ages of 7, 11, 16 and 23 years. Of the 870 cases with examined or reported eczema by the age of 16 years, 66% had age of onset by the age of 7 years. Of the 571 children with reported or examined eczema by the age of 7 years, the proportion of children who were clear in terms of examined eczema or reported eczema in the last year at ages 11 and 16 years was 65% and 74%, respectively. These 'apparent' or short-term clearance rates fell to 53% and 65%, respectively, after allowance for subsequent recurrences in adolescence and early adulthood. Age of onset of community-ascertained cases of atopic eczema may be later than that reported in hospital-based studies. The long-term prognosis of childhood eczema may be worse than some previous studies have suggested, especially when subsequent recurrences are taken into account.

Entities:  

Mesh:

Year:  1998        PMID: 9892950     DOI: 10.1046/j.1365-2133.1998.02509.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  32 in total

1.  Allergic sensitization and filaggrin variants predispose to the comorbidity of eczema, asthma, and rhinitis: results from the Isle of Wight birth cohort.

Authors:  A H Ziyab; W Karmaus; H Zhang; J W Holloway; S E Steck; S Ewart; S H Arshad
Journal:  Clin Exp Allergy       Date:  2014-09       Impact factor: 5.018

2.  Variations in risk of asthma and seasonal allergies between early- and late-onset pediatric atopic dermatitis: A cohort study.

Authors:  Joy Wan; Nandita Mitra; Ole J Hoffstad; Joel M Gelfand; Albert C Yan; David J Margolis
Journal:  J Am Acad Dermatol       Date:  2017-08-14       Impact factor: 11.527

Review 3.  [Inpatient rehabilitation of chronic dermatoses illustrated by atopic dermatitis].

Authors:  W Nürnberg
Journal:  Hautarzt       Date:  2005-07       Impact factor: 0.751

4.  Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children: A cohort study.

Authors:  Joy Wan; Nandita Mitra; Ole J Hoffstad; Albert C Yan; David J Margolis
Journal:  J Am Acad Dermatol       Date:  2019-05-11       Impact factor: 11.527

5.  Experiences of carers managing childhood eczema and their views on its treatment: a qualitative study.

Authors:  Miriam Santer; Hana Burgess; Lucy Yardley; Steven Ersser; Sue Lewis-Jones; Ingrid Muller; Catherine Hugh; Paul Little
Journal:  Br J Gen Pract       Date:  2012-04       Impact factor: 5.386

Review 6.  The Long-Term Course of Atopic Dermatitis.

Authors:  Katrina Abuabara; David J Margolis; Sinéad M Langan
Journal:  Dermatol Clin       Date:  2017-04-22       Impact factor: 3.478

7.  Disease severity and associated family impact in childhood atopic dermatitis.

Authors:  R Balkrishnan; T S Housman; C Carroll; S R Feldman; A B Fleischer
Journal:  Arch Dis Child       Date:  2003-05       Impact factor: 3.791

8.  First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis.

Authors:  Ian A Myles; Noah J Earland; Erik D Anderson; Ian N Moore; Mark D Kieh; Kelli W Williams; Arhum Saleem; Natalia M Fontecilla; Pamela A Welch; Dirk A Darnell; Lisa A Barnhart; Ashleigh A Sun; Gulbu Uzel; Sandip K Datta
Journal:  JCI Insight       Date:  2018-05-03

9.  Polymorphisms in the interleukin 13 and GATA binding protein 3 genes and the development of eczema during childhood.

Authors:  S H Arshad; W Karmaus; R Kurukulaaratchy; A Sadeghnejad; M Huebner; S Ewart
Journal:  Br J Dermatol       Date:  2008-04-10       Impact factor: 9.302

10.  Persistence of mild to moderate atopic dermatitis.

Authors:  Jacob S Margolis; Katrina Abuabara; Warren Bilker; Ole Hoffstad; David J Margolis
Journal:  JAMA Dermatol       Date:  2014-06       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.